Turner N, Dent RA, O'Shaughnessy J, Kim SB, et al. Ipatasertib plus paclitaxel for PIK3CA/AKT1/PTEN-altered hormone receptor-positive HER2-negative advanced breast cancer: primary results from cohort B of the IPATunity130 randomized phase 3 trial. Breast Cancer Res Treat 2021 Dec 3. pii: 10.1007/s10549-021-06450.
PMID: 34860318